Outcome of oral immunotherapy for persistent cow's milk allergy from 11 years of experience in Finland.

Tiina Kaisa KauppilaMarita PaassiltaAnna Kaarina KukkonenMikael KuitunenAnna S PelkonenMika J Makela

Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2019)

More than half of the patients were able to maintain the targeted milk dose in their daily diet. Baseline milk sIgE level and reactivity during the early treatment stage strongly predicted the long-term outcome and safety of milk OIT.

Keyphrases

end stage renal disease
physical activity
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
drug delivery
patient reported outcomes
replacement therapy